Advertisement

Introduction

  • Dietrich Schmähl
  • Carlos Thomas
  • Rolf Auer

Abstract

In recent years iatrogenic carcinogenesis has become an important field of iatrogenic pathology (Geyer, 1955; Druckrey, 1956; Schmäht, 1959; 1972; Uehlinger, 1961; Olbert, 1962; Lampert, 1964; Spain et al., 1967; Truhaut, 1967; Belpomme et al., 1972; Thomas, 1972; Goertt1er, 1972; Karrer and Wrba, 1972; Clayson, 1972; Waldenström, 1974; Deichmann, 1975; Preussmann, 1975). It is difficult to establish a relation between a specific therapy and the occurrence of a tumor, because these tumors often have latency periods of several years or even decades and because man is exposed continuously to various environmental carcinogenic factors. Therefore a syncarcinogenic action of both a specific drug and various other carcinogens has to be considered in most cases.

Keywords

Thyroid Cancer Thyroid Carcinoma Thyroid Nodule Potential Carcinogen Radioiodine Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Araki, M., Oshiro, K.: Papillary adenocarcinoma of the thyroid developing after treatment of hyperthyroidism with 131 I. Gann 61, 267 (1970)PubMedGoogle Scholar
  2. Baker, H. W.: Anaplastic thyroid cancer twelve years after radioiodine therapy. Cancer (Philad.) 23, 885 (1969)CrossRefGoogle Scholar
  3. Belpomme, D., Blondel, P., Mathé, G.: Les cancers d’origine thérapeutique. Vie. Med. Canada Franc. 1, 140 (1972)Google Scholar
  4. Bross, D. J., Natarajan, N.: Risk of leukemia in suspectible children exposed to preconception, in utero and postnatal radiation. Prey. Med. 3, 361 (1974)CrossRefGoogle Scholar
  5. Burke, G., Levinson, M. J., Zitman, I.: Thyroid carcinoma ten years after sodium iodide I 131 treatment. J. Amer. Med. Ass. 199, 247 (1967)CrossRefGoogle Scholar
  6. Clayson, D. B.: Carcinogenic hazards due to drugs. In: Drug-Induced Diseases. Meyler, L., Peck, H. M. (eds.) Amsterdam: Excerpta Medica, 1972, Vol. IV, pp. 91–109Google Scholar
  7. Deichmann, W. B.: Cummings Memorial Lecture, 1975. J. Amer. Ind. Hyg. Ass. 33, 411 (1975)CrossRefGoogle Scholar
  8. Druckrey, H.: Krebserzeugende Eigenschaften bei Arzneimitteln. Muench. med. Wschr. 98, 295 (1956)Google Scholar
  9. Geyer, A.: Zur Frage der iatrogenen Krebse. Z. inn. Med. 10, 685 (1955)Google Scholar
  10. Goerttler, K.: Modell und Wirklichkeit der iatrogenen Carcinogenese. Verh. Dtsch. Ges. Path. 56, 138 (1972)Google Scholar
  11. Karrer, K., Wrba, H.: Bedeutung der iatrogenen Cancerogenese. Verh. Dtsch. Ges. Path. 56, 164 (1972)Google Scholar
  12. Lampert, F.: latrogene Schäden. Med. Klin. 59, 1001 (1964)PubMedGoogle Scholar
  13. McDougall, I. R., Kennedy, J. S., Thomson, J. A.: Thyroid carcinoma following iodine-131 therapy. Report of a case and review of the literature. J. Clin. Endocr. 33, 287 (1971)PubMedCrossRefGoogle Scholar
  14. Miller, R. W.: Radiation induced cancer. J. Nat. Cancer Inst. 49, 1221 (1972)PubMedGoogle Scholar
  15. Modan, B., Lilienfeld, A. M.: Leukaemogenic effect of ionising-irradiation treatment in polycythaemia. Lancet 2, 439 (1964)CrossRefGoogle Scholar
  16. Mole, R. H.: Late effects of radiation: Carcinogenesis. Brit. Med. Bull. 29, 78 (1973)PubMedGoogle Scholar
  17. Olbert, Th.: latrogene Karzinogene. Krebsarzt 17, 154 (1962)PubMedGoogle Scholar
  18. Pack, C. T., Davis, J.: Radiation cancer of the skin. Radiology 84, 436 (1965)PubMedGoogle Scholar
  19. Phillips, T. L., Sheline, G. E.: Bone sarcoma following radiation therapy. Radiology 81, 992 (1963)PubMedGoogle Scholar
  20. Preussmann, R.: Chemische Carcinogene in der menschlichen Umwelt. In: Handbuch der allgemeinen Pathologie. Geschwülste/Tumors II. Altmann, H.-W., Büchner, F., Cottier, H., Grundmann, E., Holle, G., Letterer, E., Masshoff, W., Meesen H., Roulet, F., Seifert, G., Siebert, G. (eds.) Berlin-Heidelberg-New York: Springer, 1975, Vol. 6, Part 6, pp. 421–594Google Scholar
  21. Schmähl, D.: Gibt es krebserzeugende Arzneimittel? Mentor Medici 18, 343 (1959)Google Scholar
  22. Schmähl, D.: Toxikologische Probleme der iatrogenen Carcinogenese. Verh. Dtsch. Ges. Path. 56, 133 (1972)Google Scholar
  23. Seydel, H. G.: The risk of tumor induction in man following medical irradiation for malignant neoplasm. Cancer (Philad.) 35, 1641 (1975)CrossRefGoogle Scholar
  24. Sheline, G. E., Lindsay, S., Bell, H. G.: Occurrence of thyroid nodules in children following therapy with radioiodine for hyperthyroidism. J. Clin. Endocr. 19, 127 (1959)PubMedCrossRefGoogle Scholar
  25. Silva Horta, D. A. J., Abatt, J. D., Cayolla da Motta, L., Roriz, M. L.: Malignancy and other late effects following administration of thorotrast. Lancet 2, 201 (1965)CrossRefGoogle Scholar
  26. Spain, D. M., Kowal, S. J., Lunger, M., Shapiro, A., Slatkin, M. R., Warwhaw, L. J.: Iatrogene Krankheiten. Stuttgart: Georg Thieme 1967Google Scholar
  27. Staffurth, J. S.: Thyroid cancer after 131 I therapy for thyrotoxicosis. Brit. J. Radiol. 39, 471 (1966)PubMedCrossRefGoogle Scholar
  28. Thomas, C.: Systematik der iatrogenen Cancerogenese. Verh. Dtsch. Ges. Path. 56, 126 (1972)Google Scholar
  29. Totten, R. S., Antypas, P. G., Supertius, S. M., Gaisford, J. C., White, W. L.: Pre-existing roentgen-ray dermatitis in patients with skin cancer. Cancer (Philad.) 10, 1024 (1957)CrossRefGoogle Scholar
  30. Truhaut, R. (ed.): Potential carcinogenic hazards from drugs. UICC Monograph Series, Vol. VII, Berlin-Heidelberg-New York: Springer 1967Google Scholar
  31. Uehlinger, E.: Pathologische Anatomie der Therapieschäden. Verh. Dtsch. Ges. inn. Med. 67, 457 (1961)Google Scholar
  32. Waldenström, J. G.: Iatrogene maligne Zustände. Med. Welt 25, 669 (1974)PubMedGoogle Scholar
  33. Wegener, K., Wesch, H., Kampmann, H.: Retikuloendotheliales System und Thorotrastose nach diagnostischer Angiographie. Dtsch. med. Wschr. 96, 1977 (1971)PubMedCrossRefGoogle Scholar
  34. Wenz, W.: Thorotrasttumoren. Quantitative Untersuchungen über das Dosis-Wirkungs-problem bei Thorotrastose. Ergebn. Chir. 46, 81 (1964)Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1977

Authors and Affiliations

  • Dietrich Schmähl
    • 1
  • Carlos Thomas
    • 2
  • Rolf Auer
    • 2
  1. 1.Institut für Toxikologie und ChemotherapieDeutsches KrebsforschungszentrumHeidelbergDeutschland
  2. 2.Pathologisches InstitutUniversität FreiburgFreiburg i. Br.Federal Republic of Germany

Personalised recommendations